Live prices

Novi vs TMates: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
54 providers verified independently·Independent researchHow we rank →

Novi and TMates are tied at 7.8/10. Published pricing is not a like-for-like monthly comparison: Novi is from $133/mo; TMates is from $158/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose TMates for users who want commitment-discount pricing on compounded glp.

A side-by-side look at Novi and TMates to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Novi

#9 of 54
7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

TMates

#11 of 54
7.8/10

Telemedicine platform offering two distinct archetypes: compounded semaglutide and tirzepatide with medication included (commitment pricing $158-$249/mo), and a clinical-service-only path to brand-name Wegovy/Zepbound at $99/mo where the prescription is sent to the patient's pharmacy. Phentermine also available. 2026 expansion added brand-name FDA-approved options.

Visit TMates
FeatureNoviTMates
Why each oneCombination of six named clinicians (most compounded-only platforms disclose zero or one), month-to-month billing with no commitment, and aggressive promotional pricing as low as $99/mo on the offer landing, a flexibility-and-headcount profile most direct competitors at this price tier do not match.Two-archetype platform: (1) compounded GLP-1s with medication included and steep multi-month commitment discounts; (2) cheap $99/mo clinical service for brand Wegovy/Zepbound where you fill the prescription at your own pharmacy.
Our Score7.8/107.8/10
Headline Pricefrom $133/mofrom $158/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoYes
Best ForCash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offerUsers who want commitment-discount pricing on compounded GLP-1s ($158-$249/mo, medication included) or a $99/mo clinical path to brand Wegovy or Zepbound filled at their own pharmacy
Watch out forCompounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formatsThe $99/mo Wegovy/Zepbound tier is the clinical service only. Medication is billed separately at your pharmacy (can be $1,000+/mo cash without insurance). Choose this tier when your insurance covers the drug itself.
Ranking#9#11
Get startedVisit NoviVisit TMates

Pros & Cons Compared

Novi

Pros

  • +Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
  • +Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
  • +Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
  • +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
  • +Free 2-day shipping; Novi markets compounded semaglutide and tirzepatide, which are not FDA-approved brands or generics and are not established as equivalent to Wegovy, Ozempic, Mounjaro, or Zepbound
  • +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

  • Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
  • Founding year, headquarters city, and corporate ownership are not publicly disclosed
  • Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
  • Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
  • Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
  • Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

TMates

Pros

  • +Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
  • +Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
  • +Same price at all dose levels for compounded, no cost escalation as you titrate up
  • +Phentermine available at $149/mo for patients who benefit from a different appetite-suppressant approach

Cons

  • The $99/mo Wegovy/Zepbound tier is the clinical service only. Medication is billed separately at your pharmacy (can be $1,000+/mo cash without insurance). Choose this tier when your insurance covers the drug itself.
  • The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
  • The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.
  • TMates prescribes brand-name but does not dispense it, and is not affiliated with Novo Nordisk (Wegovy) or Eli Lilly (Zepbound). Your own pharmacy fills the Rx.

Our Verdict

Novi and TMates are closely matched with identical scores of 7.8/10. Published pricing is not a like-for-like monthly comparison: Novi is from $133/mo; TMates is from $158/mo. TMates accepts insurance, which can significantly reduce your out-of-pocket costs. TMates offers both brand-name and compounded medications, giving you more flexibility. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose TMates if you want: users who want commitment-discount pricing on compounded glp-1s ($158-$249/mo, medication included) or a $99/mo clinical path to brand wegovy or zepbound filled at their own pharmacy.

Try Novi

Headline price: from $133/mo

Visit Novi

Try TMates

Headline price: from $158/mo

Visit TMates

Related comparisons

Other matchups readers comparing Novi or TMates tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.